ENTITY

Medexus Pharmaceuticals (MEDXF US)

9
Analysis
Health Care • Canada
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on therapeutic areas such as rheumatology, auto-immune disease, specialty oncology, and pediatrics. Medexus Pharmaceuticals serves customers North America and Canada.
more
•04 Mar 2025 12:33

Best Ideas of 2025

The range of ideas is broad. The smallest market cap is a $15MM Canadian micro-cap that is trading below its net cash, and the largest is an $25BN...

Logo
440 Views
Share
•03 Mar 2025 09:26

Best Idea of 2025: Medexus Pharmaceuticals

Medexus (MDP.TO / MEDXF) is my best idea for 2025. The stock trades at a distressed valuation despite the current launch of a new drug that could...

Logo
293 Views
Share
bullish•Comcast Corp Class A
•24 Nov 2025 13:00

Weekly Update (MEDXF, MAGN, LEN/MRP, MODG)

Comcast (CMCSA) announced in late 2024 that it would spin off a bundle of its traditional U.S. cable networks and related digital properties into...

Logo
157 Views
Share
bullish•Starz
•17 Nov 2025 09:15

Weekly Update (MICC, MEDXF, STRZ)

The Wall Street Journal recently published a good article highlighting that streaming costs are soaring but consumers continue to be willing to...

Logo
181 Views
Share
bullish•Corteva
•06 Oct 2025 09:44

Weekly Update (CTVA, SFGI/8729, UNTC, MEDXF, IDT)

On October 1, 2025, Corteva Biosciences (CTVA) announced that it plans to break up into two public companies. The logic behind the spin-off...

Logo
147 Views
Share
x